Connect with us
European Gaming Congress 2024

Artificial Intelligence

Transfection Reagent and Equipment Market Estimated to Witness Exponential CAGR Growth of 9.6% by 2030, Size, Share, Trends, Rising Demand, Dynamics and Opportunity Analysis

Published

on

 

Data Bridge Market Research has recently published a Report, titled, “Transfection Reagent and Equipment Market” The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five Forces analysis, and competitive landscape. Market insights underlined in Transfection Reagent and Equipment report will help foster a future shaped by growth in the face of unprecedented health and economic challenges. Market data and information covered here bridges the strategic gap with revenue impacting solutions. It also aids outwit the challenges including the economic challenges created by covid-19. Market research report services have modernized strategy making with actionable insights and with the largest industry and technology coverage that is never seen before in the industry. While delivering Transfection Reagent and Equipment report to the client, the timeline is religiously followed.

With unparalleled level of resilience and integrated approaches, DBMR team works hard to provide the finest Transfection Reagent and Equipment market report. This report helps unearth the best market opportunities and foster efficient information for the business to thrive in the market. The market document provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process. We believe in delivering the best before the clock ticks deadline. Moreover, after delivering Transfection Reagent and Equipment report to the client, an extremely particular post-sales support is provided to the clients about addressing all the queries and requests generated by them with phenomenal performance.

Data Bridge Market Research analyzes that the global transfection Reagent and equipment market is expected to reach the value of USD 2,284,494.00 thousand by 2030, at a CAGR of 9.6% during the forecast period.

Download Sample Copy of Transfection Reagent and Equipment Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-transfection-reagents-and-equipment-market

Advertisement
Stake.com

The transfection method is used to introduce RNA, DNA or protein products in cells to alter the phenotype and genotype of the organism. The transfection method involves the new gene transfer or transferring a gene construct such as Clustered regularly interspaced short palindromic repeats (CRISPR) for genome editing purposes. Transfection has wide applications in the field of immunotherapy, gene therapy, and cell therapy, among others. Transfection involves both non-viral and viral-mediated transfection

The transfection method is used for several applications involving agriculture for crop protection and enhancing yield, for the production of synthetic biology products to enhance flavors and fragrances, and for enhancing single-cell protein, among others. The demand for transfection has increased in both developed and developing countries, and the reason behind this is the increasing occurrence of chronic diseases. The transfection market is growing due to the growing demand for chimeric genes and the utilization of biopharmaceuticals in the production of proteins. The market will grow in the forecast period due to the exploration of emerging markets, strategic initiatives by market players, and increasing government support.

The high cost of instruments, selective effectiveness of transfection reagent and cell damage induced by the transfection methods are expected to restrain the global transfection reagent and equipment market growth.

The market is growing due to several strategic initiatives adopted by market players involving acquisition, collaboration, and partnership.

Recent Developments

Advertisement
Stake.com
  • In August 2021, Mirus Bio expanded the TransIT VirusGen platform for Good Manufacturing Practice (GMP) viral vector production to support cell and gene therapy development, process operations, and commercial production. The extension, referred to as TransIT VirusGen GMP Transfection Reagent, is designed to improve the packaging and delivery of vector DNA to suspension and adherent HEK 293 cell types to improve the production of recombinant adeno-associated viruses and lentiviral vectors.
  • In April 2021, BOC Sciences announced the launch of two in vivo RNA transfection kits, namely siRNA in vivo transfection kits and mRNA in vivo transfection kits, suitable for in vivo transfection of siRNA and mRNA, respectively.

Some of the major players operating in the Transfection Reagent and Equipment market are:

  • Mirus Bio LLC.
  • Promega Corporation
  • Polyplus Transfection
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Lonza
  • MaxCyte, Inc.
  • Altogen Biosystems
  • SBS Genetech
  • FUJIFILM Irvine Scientific (A Subsidiary of FUJIFILM Holdings Corporation)
  • Avanti Polar Lipids (A Subsidiary of Croda International Plc)
  • PerkinElmer chemagen Technologie GmbH (A Subsidiary of PerkinElmer Inc.)
  • Cytiva
  • Geno Technology Inc., USA
  • R&D Systems, Inc.
  • Takara Bio Inc.
  • Thermofisher Scientific Inc.
  • Roche Molecular Systems, Inc. (A Subsidiary of F. Hoffmann-La Roche Ltd)
  • QIAGEN
  • OriGene Technologies, Inc.
  • Applied Biological Materials Inc. (abm)
  • Beckman Coulter, Inc. (A Subsidiary of Danaher)
  • Amyris
  • Codexis
  • Autolus
  • SignaGen Laboratories
  • Impossible Foods Inc.
  • Genlantis Inc.
  • Ginkgo Bioworks
  • Verve Therapeutics, Inc.
  • Conagen, Inc.
  • Poseida Therapeutics, Inc.
  • Twist BioscienceTop of Form

Get Full PDF Research Report to Understand More @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-transfection-reagents-and-equipment-market

Opportunities:

EXPLORATION OF EMERGING MARKET

The transfection products have been shown as promising tools for the genetic engineering and proteomic industry. The top market for transfection products is in Europe and North America. By looking at the positive outcomes of these products, many market players are penetrating their roots in growing economies involving China and India, among others. The emerging market allows these market players to combat the loss that arises from the well-established market.

As emerging markets allow the market players to overcome the economic downturn specified to particular established markets, investment and exploration of emerging markets allow the market players to engage in the development and manufacturing of transfection products to attain lucrative growth. Thus, this signifies that exploring emerging markets is an opportunity to grow the global transfection Reagent and equipment market.

The report provides insights on the following pointers:

Advertisement
Stake.com

Market Penetration: Comprehensive information on the product portfolios of the top players in the Transfection Reagent and Equipment market

Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the market

Competitive Assessment: In-depth assessment of the market strategies, and geographic and business segments of the leading players in the market

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Transfection Reagent and Equipment Market

Advertisement
Stake.com

Market Dynamics: Transfection Reagent and Equipment Market

  • RISE IN THE PREVALENCE OF CHRONIC DISEASES

The prevalence of chronic diseases is increasing worldwide, leading to the demand for effective and accurate treatment. Transfection is used to deliver targeted modified genes to treat several genetic diseases. The transfection method is also used for the delivery of the CRISPR gene, which can enhance adaptive immunity and prevent an individual from different diseases.

The increasing cases of chronic diseases such as COVID-19 and other infectious diseases have led to the discovery of effective gene therapy products which can replace the defective gene with the correct gene. The transfection method is widely used for gene therapy, among others. As the demand for effective and accurate treatment is increasing worldwide, the demand for gene therapy and transfection method is also increasing. Moreover, several undergoing researches proving gene therapy to have the potential for chronic disease treatment are also increasing its demand among physicians and patients. This thus signifies that the rise in chronic disease prevalence is acting as a driver for the global transfection Reagent and equipment market growth.

  • DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS

Synthetic biology is a new era of biology that incorporates the engineering principle into biology. Synthetic biology involves the chemical synthesis of DNA by combining the knowledge of genomics to reassemble the DNA genomes. The synthetic biology that sequences into the new genes involves genetic engineering, which incorporates the transfection method, among others. As the demand for synthetic biology products is increasing worldwide, the use of transfection products is also increasing.

The demand for synthetic biology products is increasing due to the increasing demand for effective and innovative products. The manufacturing of synthetic products enhances the demand for transfection products, as gene transfer can be accompanied by the transfection method, among others. Thus, this signifies that synthetic product development drives the global transfection Reagent and equipment market growth.

A comprehensive analysis will be provided covering the following points in the report:

  • Executive Market Summary
  • Scope of the Transfection Reagent and Equipment Report
  • Key Finding and Recommendations
  • Growth and Investment Opportunities
  • Transfection Reagent and Equipment Market Value Chain/Supply Chain Analysis
  • Transfection Reagent and Equipment Market Attractive Investment Proposition
  • Competitive landscape and SWOT Analysis
  • Transfection Reagent and Equipment Market Segmentation Outlook
  • Regional Outlook
  • Company Profiles of Key Players

Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global Transfection Reagent and Equipment market over the period. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

To Gain More Insights about this Research, Visit @ https://www.databridgemarketresearch.com/reports/global-transfection-reagents-and-equipment-market

Advertisement
Stake.com

Key Industry Segmentation: Transfection Reagent and Equipment Market

Products

  • Instruments
  • Reagent & Kits

Stage

  • Research
  • Preclinical
  • Clinical Phases
  • Commercial

Type

  • Transient Transfection Reagent And Equipment
  • Stable Transfection Reagent And Equipment

Methods

  • Non-Viral Methods
  • Viral Methods

Types Of Molecule

  • Plasmid Dna
  • Dna Oligonucleotides
  • Small Interfering Rna (Sirna)
  • Proteins
  • Ribonucleoprotein Complexes (Rnps)
  • Others

Organism

  • Bacteria
  • Mammalian Cells
  • Fungi
  • Plants
  • Virus

Application

  • By Type
    • In Vitro Application
    • In Vivo Application
    • Bioproduction
    • Others
  • By Industry
    • Agriculture
    • Synthetic Biology
    • Others

End User

  • Biopharma
  • Cros
  • Cmos/Cdmos
  • Academia
  • Hospitals
  • Clinical Labs
  • Others

Distribution Channel

  • Direct Tender
  • Retail Sales

Regional Analysis/Insights: Transfection Reagent and Equipment Market

The countries covered in this Transfection Reagent and Equipment market report are U.S., CanadaMexicoGermanyFranceItaly, U.K., SpainSwitzerlandRussiaNetherlandsBelgiumTurkey, and Rest of EuropeChinaJapanIndiaAustraliaSouth KoreaSingaporeThailandMalaysiaPhilippinesIndonesia, and Rest of Asia-PacificBrazilArgentina, Rest of South AmericaSouth AfricaSaudi Arabia, UAE, IsraelEgypt, and Rest of the Middle East and Africa

In 2023, the North America region is dominating due to the presence of key market players in the largest consumer market with high GDP. U.S is expected to grow due to rise in the prevalence of chronic and rare diseases leading to increase in the use of transfection reagent and equipment.

North America is dominating the market due to the increasing investment in healthcare is expected to boost the market growth. The U.S. dominates North America region due to strong presence of key players. Germany dominates Europe region due to the increasing demand from emerging markets and expansion. China dominates Asia-Pacific region due to due to increasing customer inclinations towards advanced technological processes.

Advertisement
Stake.com

Table of Contents:

1.  Introduction

2.  Market Segmentation

3.  Executive Summary

4.  Premium Insights

Advertisement
Stake.com

5.  Global Transfection Reagent and Equipment Market: Regulations

6.  Market Overview

7.  Global Transfection Reagent And Equipment Market, By Products

8.  Global Transfection Reagent And Equipment Market, By Stage

9.  Global Transfection Reagent And Equipment Market, By Type

Advertisement
Stake.com

10.  Global Transfection Reagent And Equipment Market, By Methods

11.  Global Transfection Reagent And Equipment Market, By Types Of Molecule

12.  Global Transfection Reagent And Equipment Market, By Organism

13.  Global Transfection Reagent And Equipment Market, By Application

14.  Global Transfection Reagent And Equipment Market, By End User

Advertisement
Stake.com

15.  Global Transfection Reagent And Equipment Market, By Distribution Channel

16.  Global Transfection Reagent and Equipment Market, By Region

17.  Global Transfection Reagent and Equipment Market: Company Landscape

18.  SWOT Analyses

19.  Company Profile

Advertisement
Stake.com

20.  Questionnaires

21.  Related Reports

To Check the Complete Table of contents, click here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-transfection-reagents-and-equipment-market

Explore More Reports:

North America Transfection Reagent and Equipment Market, By Products (Reagent & Kits and Instruments), Stage (Research, Preclinical, Clinical Phases, and Commercial), Type (Transient Transfection Reagent and Equipment, Stable Transfection Reagent, and Equipment), Methods (Non-viral Methods and Viral Methods), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), and Others), Organism (Mammalian Cells, Plants, Fungi, Virus, and Bacteria), Application (In Vitro Application, In Vivo Application, Bioproduction and Others), End User (Biopharma, CROs, (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) https://www.databridgemarketresearch.com/reports/north-america-transfection-reagents-and-equipment-market

Advertisement
Stake.com

Europe Transfection Reagent and Equipment Market, By Products (Reagent & Kits and Instruments), Stage (Research, Preclinical, Clinical Phases, and Commercial), Type (Transient Transfection Reagent and Equipment, Stable Transfection Reagent, and Equipment), Methods (Non-viral Methods and Viral Methods), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), and Others), Organism (Mammalian Cells, Plants, Fungi, Virus, and Bacteria), Application (In Vitro Application, In Vivo Application, Bioproduction and Others), End User (Biopharma, CROs, (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) https://www.databridgemarketresearch.com/reports/europe-transfection-reagents-and-equipment-market

Asia-Pacific Transfection Reagent and Equipment Market, By Products (Reagent & Kits and Instruments), Stage (Research, Preclinical, Clinical Phases, and Commercial), Type (Transient Transfection Reagent and Equipment, Stable Transfection Reagent, and Equipment), Methods (Non-viral Methods and Viral Methods), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), and Others), Organism (Mammalian Cells, Plants, Fungi, Virus, and Bacteria), Application (In Vitro Application, In Vivo Application, Bioproduction and Others), End User (Biopharma, CROs, (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) https://www.databridgemarketresearch.com/reports/asia-pacific-transfection-reagents-and-equipment-market

Middle East and Africa Transfection Reagent and Equipment Market, By Products (Reagent & Kits and Instruments), Stage (Research, Preclinical, Clinical Phases, and Commercial), Type (Transient Transfection Reagent and Equipment, Stable Transfection Reagent, and Equipment), Methods (Non-viral Methods and Viral Methods), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), and Others), Organism (Mammalian Cells, Plants, Fungi, Virus, and Bacteria), Application (In Vitro Application, In Vivo Application, Bioproduction and Others), End User (Biopharma, CROs, (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) https://www.databridgemarketresearch.com/reports/middle-east-and-africa-transfection-reagents-and-equipment-market

Cancer Diagnostics Market, By Product (Consumables, Instruments), Type (Imaging Testing, Biomarkers Testing, In Vitro Diagnostic Testing, Biopsy, Others), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma Cancer, Prostate Cancer, Liver Cancer, Others), End-User (Diagnostic Centres, Hospitals and Clinics, Research Institutes, Others) https://www.databridgemarketresearch.com/reports/global-cancer-diagnostics-market

Arthritis Market, By Rheumatoid Drug Type (Biologics, Non-Biologics, Steroids, Analgesics, Glucocorticoids, Others), Rheumatoid Treatment (Synovectomy, Tendon Repair, Joint Fusion, Symptomatic Treatment, Intermediate Corticosteroid Therapies, DMARD Therapies), Rheumatoid Diagnosis (CRP Test, CCP, ESR Test), Osteoarthritis Type (Hip, Spinal, Knee, Foot and Ankle, Shoulder, Hand), Osteoarthritis Treatment (Medication, Drugs, Assistive Devices, Surgery, Therapy), Osteoarthritis Diagnosis (Imaging, Joint Fluid Analysis, Others), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Clinics, Household, Medical Institutes, Research Organizations, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Drug Stores), Country (U.S., CanadaMexicoBrazilArgentinaPeru, Rest of South AmericaGermanyFrance, U.K., NetherlandsSwitzerlandBelgiumRussiaItalySpainTurkeyHungaryLithuaniaAustriaIrelandNorwayPoland, Rest of EuropeChinaJapanIndiaSouth KoreaSingaporeMalaysiaAustraliaThailandIndonesiaPhilippinesVietnam, Rest of Asia-PacificSaudi Arabia, U.A.E, EgyptIsraelKuwaitSouth Africa, Rest of Middle East and Africahttps://www.databridgemarketresearch.com/reports/global-arthritis-market

Advertisement
Stake.com

Artificial Intelligence in Medical Imaging Market, By Technology (Deep Learning, Computer Vision, NLP, Others), Offering (Hardware, Software, Services), Deployment Type (On-Premise, Cloud), Application (X-Ray, CT, MRI, Ultrasound, Molecular Imaging), Clinical Applications (Breast, Lung, Neurology, Cardiovascular, Liver, Prostate, Colon, Musculoskeletal, Others), End-User (Hospitals, Clinics, Research Laboratories, Others), Country (U.S., CanadaMexicoGermanyItaly, U.K., FranceSpainNetherlandsBelgiumSwitzerlandTurkeyRussia, Rest of EuropeJapanChinaIndiaSouth KoreaAustraliaSingaporeMalaysiaThailandIndonesiaPhilippines, Rest of Asia- PacificBrazilArgentina, Rest of South AmericaSouth AfricaSaudi Arabia, UAE, EgyptIsrael, Rest of Middle East & Africahttps://www.databridgemarketresearch.com/reports/global-artificial-intelligence-in-medical-imaging-market

Aspirin Market, By Route of Administration (Oral, Rectal, Parenteral), Dosage Form (Tablets, Capsules, Injections, Suppositories), Applications (Pain, Fever and Inflammation, Deep Vein Thrombosis and Others), Dose Type (Adult Dose and Pediatric Dose), Availability (Prescription and OTC), Product Type (Alone and Combination Products), End User (Hospitals, Clinics, Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), Country (U.S., CanadaMexicoBrazilArgentinaPeru, Rest of South AmericaGermanyFrance, U.K., NetherlandsSwitzerlandBelgiumRussiaItalySpainTurkeyHungaryLithuaniaAustriaIrelandNorwayPoland, Rest of EuropeChinaJapanIndiaSouth KoreaSingaporeMalaysiaAustraliaThailandIndonesiaPhilippinesVietnam, Rest of Asia-PacificSaudi Arabia, U.A.E., EgyptIsraelKuwaitSouth Africa, Rest of Middle East and Africahttps://www.databridgemarketresearch.com/reports/global-aspirin-market

Injectable Drug Delivery Market, By Type (Injectable Drug Delivery Devices, Injectable Drug Delivery Formulation), Formulation Packaging (Ampoules, Vials, Cartridges, Bottles), Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Cancer, Others),  Usage Pattern (Curative Care, Immunization, Other), Site Of Administration (Skin, Circulatory/Musculoskeletal System, Organs, Central Nervous System), Distribution Channel (Hospital, Retail Pharmacy Stores), End User (Hospitals and Clinics, Home Care Settings, Others) https://www.databridgemarketresearch.com/reports/global-injectable-drug-delivery-market

Topical Drug Delivery Market, By Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products), Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery), Distribution Channel (Direct Tenders, Retail), End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others) https://www.databridgemarketresearch.com/reports/global-topical-drug-delivery-market

North America Topical Drug Delivery Market, Product Type (Drug Delivery Formulations and Drug Delivery Devices), Delivery Techniques (Ionotophoresis, Sonophoresis, Laser Ablation, Radio Frequency Ablation, Magnetophoresis, Electroporation And Others), Type (Cleansing Agents, Protective Agents, Moisturizing Agents, Drying Agents, Anti-Itch Agents, Anti-Inflammatory Agents, Anti-Infective Agents, Keratolytics, and Others), Generation (First Generation Transdermal Delivery Systems, Second Generation Transdermal Delivery Systems and Third Generation Transdermal Delivery Systems), Mode of Purchase (Prescription and Over The Counter), Indication (Dermatological Disorders, Ophthalmic Disorders, Pain Management, Neurosurgical Disorders, Hormonal Therapy, Smoking Cessation and Others), Route of Administration (Dermal, Ophthalmic, Rectal, Vaginal, Nasal and Others), End User (Hospitals, Specialty Centers, Home Healthcare, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others) https://www.databridgemarketresearch.com/reports/north-america-topical-drug-delivery-market

Advertisement
Stake.com

Drug Delivery Devices Market, By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Others), Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Others) https://www.databridgemarketresearch.com/reports/global-drug-delivery-devices-market

North America Drug Delivery Devices Market, By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery and Implantable Drug Delivery), Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings and Others), Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders and Others), Country (U.S., CanadaMexicohttps://www.databridgemarketresearch.com/reports/north-america-drug-delivery-devices-market

Artificial Intelligence (AI) in Drug Discovery Market, By Application (Novel Drug Candidates, Drug Optimization and Repurposing Preclinical Testing and Approval, Drug Monitoring, Finding New Diseases Associated Targets and Pathways, Understanding Disease Mechanisms, Aggregating and Synthesizing Information, Formation & Qualification of Hypotheses, De Novo Drug Design, Finding Drug Targets of an Old Drug and Others), Technology (Machine Learning, Deep Learning, Natural Language Processing and Others), Drug Type (Small Molecule and Large Molecule), Offering (Software and Services), Indication (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases and Others), End Use (Contract Research Organizations (CROs), Pharmaceutical & Biotechnology Companies, Research Centers and Academic Institutes and Others) https://www.databridgemarketresearch.com/reports/global-artificial-intelligence-ai-in-drug-discovery-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Advertisement
Stake.com

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Artificial Intelligence

ResourceWise Brings Its Cross-Commodity Data and Analytics Expertise to New Oleochemicals Service

Published

on

resourcewise-brings-its-cross-commodity-data-and-analytics-expertise-to-new-oleochemicals-service

ResourceWise has met a key milestone in providing cross-commodity price benchmarks, data, and analysis on chemicals, forest products, and decarbonization markets. 
CHARLOTTE, N.C., June 24, 2024 /PRNewswire/ — ResourceWise has met a key milestone in providing cross-commodity price benchmarks, data, and analysis on chemicals, forest products, and decarbonization markets. 

For the first time, one digital product encompasses expertise that spans all the key commodity sectors that ResourceWise covers. Dedicated to renewable feedstock, the new platform-based oleochemicals analysis and insight tools draw on decades of experience within each distinct business sector. 
Dwight Lynch, Biomaterials Business Manager at ResourceWise, is leading the transition towards data and insight on renewable intermediates and biobased and biodegradable polymer inputs. 
“Navigating oleochemicals markets at a time when regulation, legislation, and competition from renewable fuels markets are the key drivers is a challenge. Our new service offers pricing and analysis that informs decision-makers and allows sustainable business to thrive.” 
The new oleochemicals portal in ResourceWise’s flagship chemicals market intelligence platform, OrbiChem360, has evolved beyond its legacy biomaterials insights to focus on the fats and oils markets that are key to sustainability.  
It presents pricing data and analysis that ResourceWise biomaterials experts have furnished within OrbiChem360 this past decade and includes a crude tall oil (CTO) price index. The inclusion of a forest-based output introduces the ResourceWise platform FisherSolve’s pulp and paper industry insight to our portfolio. 
Pete Stewart, the CEO of ResourceWise, is focused on the future. “From raw material converters to end-use consumer goods producers, manufacturing value chain participants are increasingly seeking cross-commodity insights to meet low-carbon targets. We are building and providing the data and analytics businesses need to achieve environmental, social, and governance (ESG) targets and market products competitively worldwide.  
“The ResourceWise mission is to use the intelligence within the increasingly inter-related business sectors we have harnessed to guide customers in their journey toward a net-zero future. This new offering is the first of many milestones in our endeavor to do just that,” adds Stewart.  
A Streamlined Renewable Chemicals Service  
The new product leverages oleochemical pricing and commentary gathered by ResourceWise legacy brands since 2014 and insight collected since the 1990s. It extends our regional reach with additional price points and streamlines the data and analytics provided.  
The new portal is designed with personal care, cosmetics, detergents, lubricants, pharmaceuticals, flavor and fragrance, and food and beverage market participants in mind. However, it provides pricing data and insights for producers, intermediaries, and consumer product manufacturers in broader industries. 
More Than Forty Current and Historical Prices          
International price indexes for oleochemicals include the feedstocks soybean, coconut, tall, rapeseed, and palm oils, as well as tallow and glycerine grades Dozens of spot and contract prices for fatty acids and fatty alcohols plus comprehensive commentary based on intelligence from a worldwide contact base       Low-carbon price benchmarks and commentary in our oleochemicals offering will increasingly leverage intelligence on the biofuels sector within the Prima CarbonZero platform      Global Trade Flow graphics for all oils and tallow to help customers understand how key plant and animal-based feedstocks are traded globally to identify new markets and sources   Industry experts contextualize data, making it actionable, and respond personally to customer inquiries By bridging information gaps in the chemicals market, OrbiChem360 subscribers gain a competitive edge in volatile markets. The platform provides decision makers with robust, data-driven insight that unravels market trends so they can harness growth opportunities. For more information on the OrbiChem360 platform, visit the ResourceWise OrbiChem360 page. 
CONTACT:
Contact:Suz-Anne Kinney          Vice President, Marketing & Communications at [email protected]  +1 (980) 233-4021
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/resourcewise/r/resourcewise-brings-its-cross-commodity-data-and-analytics-expertise-to-new-oleochemicals-service,c4005742

View original content:https://www.prnewswire.co.uk/news-releases/resourcewise-brings-its-cross-commodity-data-and-analytics-expertise-to-new-oleochemicals-service-302180514.html

Continue Reading

Artificial Intelligence

AI Vulnerability Scanning market Size to Grow USD 7,574.30 Million by 2030 at a CAGR of 13.52% | Valuates Reports

Published

on

ai-vulnerability-scanning-market-size-to-grow-usd-7,57430-million-by-2030-at-a-cagr-of-13.52%-|-valuates-reports

BANGALORE, India, June 24, 2024 /PRNewswire/ — AI Vulnerability Scanning market is Segmented by Type (On-premises, Cloud-Based), by Application (SMEs, Large Enterprise): Global Opportunity Analysis and Industry Forecast, 2024-2030.

The global AI Vulnerability Scanning market was valued at USD 3121.56 million in 2023 and is anticipated to reach USD 7,574.30 million by 2030, witnessing a CAGR of 13.52% during the forecast period 2024-2030.
Claim Your Free Sample Now: https://reports.valuates.com/request/sample/QYRE-Auto-12L15782/Global_AI_Vulnerability_Scanning_Market_Research_Report_2023
 Major Factors Driving the Growth of AI Vulnerability Scanning Market:
The market for AI vulnerability assessment is being pushed by the growing requirement for strong cybersecurity defenses against increasingly complex and dynamic cyberthreats. AI-specific vulnerabilities are becoming more likely as organizations use machine learning (ML) and artificial intelligence (AI) more extensively, which calls for the use of specialized scanning solutions. AI vulnerability scanners use cutting-edge algorithms to find and fix security flaws in AI models, shielding against criminal activity, data breaches, and adversarial attacks. The demand for AI vulnerability screening tools is being driven primarily by the increasing awareness of AI security concerns, regulatory constraints for strict data protection, and the integration of AI across multiple sectors, including banking, healthcare, and automotive. Furthermore, improvements in AI and ML methods boost these scanning solutions’ efficacy and propel the market forward.
Unlock Insights: View Full Report Now! https://reports.valuates.com/market-reports/QYRE-Auto-12L15782/global-ai-vulnerability-scanning
TRENDS INFLUENCING THE GROWTH OF THE AI VULNERABILITY SCANNING MARKET
Because cloud-based AI vulnerability scanning provides scalable, effective, and all-encompassing security solutions, it is driving the growth of the AI vulnerability scanning market in major companies. By constantly monitoring and analyzing enormous volumes of data across enterprise networks, these cloud-based systems make use of cutting-edge AI algorithms to spot possible vulnerabilities in real time. Large businesses can effectively manage security across different and complex IT infrastructures thanks to the flexibility and scalability of cloud solutions, which guarantees strong defense against constantly changing cyber threats. Furthermore, cloud-based platforms’ centralized architecture makes it simpler to integrate and upgrade with pre-existing security frameworks, which improves overall resiliency. The market is expanding significantly as a result of large organizations prioritizing cybersecurity and the increased need for advanced, AI-driven vulnerability detection solutions.
The market for AI vulnerability scanning is primarily driven by the rise in complex cyberthreats. Organizations are becoming more cognizant of the necessity for sophisticated security measures as cyber threats escalate in complexity and frequency. When it comes to identifying and countering these contemporary threats, traditional vulnerability scanning techniques frequently fall short. Real-time detection and prediction analysis capabilities are provided by AI-powered vulnerability scanning solutions, which can detect possible security breaches before they happen. Organizations must make significant investments in AI-based security solutions in order to preserve business continuity and protect critical data.
One major element propelling the market expansion for AI vulnerability scanning is regulatory compliance. Tight laws are being passed by governments and business associations across the globe to guarantee cybersecurity and data security. Sufficient observance of regulations like GDPR, HIPAA, and CCPA necessitates ongoing security vulnerability reporting and monitoring. AI vulnerability scanning systems offer thorough and automated security assessments, which assist enterprises in meeting these legal obligations. This ability not only guarantees compliance but also lowers the possibility of fines and harm to one’s reputation, which motivates more companies to choose AI-powered security solutions.
Another important element propelling the market for AI vulnerability scanning is cost effectiveness. Conventional security methods are resource-intensive and can require a large amount of manual effort, which raises operational costs. The identification and mitigation of security threats are automated by AI-powered vulnerability scanning solutions, which minimizes the need for significant human participation. Organizations save a significant amount of money because of this automation, especially big businesses with sophisticated IT infrastructures. Furthermore, early vulnerability detection reduces the possible financial effect of cyberattacks, which makes AI-driven solutions a financially viable choice for companies.
The market for AI vulnerability scanning is expanding due in large part to the need for real-time threat identification. Real-time security threat detection and response is essential in today’s fast-paced digital world. Artificial intelligence (AI)-driven vulnerability scanning solutions enable businesses to quickly respond to possible threats by offering continuous monitoring and instantaneous analysis of security weaknesses. Reducing the effects of cyberattacks and preserving the integrity of vital systems depend on this real-time detection capabilities. Adoption of AI-based security solutions is driven by the increased requirement for quick reaction to threats.
The market for AI vulnerability screening is being driven by several factors, including increased accuracy and precision. Conventional vulnerability scanning techniques can miss subtle security risks and generate false positives. On the other hand, AI-powered products use sophisticated analytics and machine learning algorithms to pinpoint vulnerabilities extremely precisely. This lowers the quantity of false alarms and guarantees that serious dangers are dealt with right away. Because AI-driven solutions are more accurate, security measures are more effective overall, which is why businesses looking for dependable and all-inclusive vulnerability management choose them.
Own It Today – Buy Now! https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-12L15782&lic=single-user
AI VULNERABILITY SCANNING MARKET SHARE ANALYSIS
The market for AI vulnerability scanning is dominated by North America because of the region’s strong emphasis on cybersecurity and technical improvements. Because there are so many tech businesses, financial institutions, and government organizations in the US that need to implement strong cybersecurity measures, the country is a big participant in this space. The development and uptake of sophisticated vulnerability scanning solutions are aided by the presence of significant AI and cybersecurity companies in the area. The industry is additionally driven by strict regulatory requirements, such as those imposed by the Health Insurance Portability and Accountability Act (HIPAA) and the Federal Information Security Management Act (FISMA), which force firms to install extensive security measures. The increased frequency of cyberattacks in North America emphasizes the necessity for sophisticated AI-powered security measures.
Key Players:
European UnionCRYPTTECHSecPointTheSmartScannerSecureWorksCybotsCyber OrionImmuniWeb SAVertaHuawei CloudFreeBufAlibaba CloudIBMGoogle CloudBARUTUAmazon AWSPurchase Regional Data: https://reports.valuates.com/request/regional/QYRE-Auto-12L15782/Global_AI_Vulnerability_Scanning_Market_Research_Report_2023
SUBSCRIPTION
We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.
DISCOVER MORE INSIGHTS: EXPLORE SIMILAR REPORTS!
–  The global artificial intelligence market size was valued at USD 65.48 billion in 2020, and is projected to reach USD 1,581.70 billion by 2030, growing at a CAGR of 38.0% from 2021 to 2030.
–  The global AI Personal Computer market was valued at USD 510 million in 2023 and is anticipated to reach USD 32850 million by 2030, witnessing a CAGR of 43.9% during the forecast period 2024-2030.
–  The global Smart Retail market was valued at USD 7383.7 million in 2023 and is anticipated to reach USD 9679.1 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
–  The vehicle scanner market was valued at USD 3.3 billion in 2021, and is estimated to reach USD 5.8 billion by 2031, growing at a CAGR of 6% from 2022 to 2031.
–  Artificial Intelligence & Advanced Machine Learning Market
–  The global AI Content Generation market was valued at USD 1400 million in 2022 and is anticipated to reach USD 5958 million by 2029, witnessing a CAGR of 27.3% during the forecast period 2023-2029.
–  The global High Performance Computing market was valued at USD 31970 million in 2023 and is anticipated to reach USD 70180 million by 2030, witnessing a CAGR of 10.7% during the forecast period 2024-2030.
–  The global conversational AI market size was valued at USD 5.78 billion in 2020 and is projected to reach USD 32.62 billion by 2030, registering a Compound Annual Growth Rate (CAGR) of 20.0% from 2021 to 2030.
–  The global cloud artificial intelligence market was valued at USD 42.7 Billion in 2022, and is projected to reach USD 887 Billion by 2032, growing at a CAGR of 35.8% from 2023 to 2032.
–  The global edge AI hardware market size was valued at USD 6.88 billion in 2020, and is projected to reach USD 38.87 billion by 2030, registering a CAGR of 18.8% from 2021 to 2030.
–  The generative ai market was valued at USD 8.15 billion in 2021, and is estimated to reach USD 126.5 billion by 2031, growing at a CAGR of 32% from 2022 to 2031.
–  The emotion AI market was valued at USD 1.8 billion in 2022, and is estimated to reach USD 13.8 billion by 2032, growing at a CAGR of 22.7% from 2023 to 2032.
–  The global AI Image Generator market was valued at USD 426 million in 2023 and is anticipated to reach USD 899.3 million by 2030, witnessing a CAGR of 11.5% during the forecast period 2024-2030.
–  The global AI Server PCB market size is expected to reach USD 197.4 million by 2029, growing at a CAGR of 12.0% from 2023 to 2029.
–  Artificial Intelligence (AI) in Mining Market
–  The global market for AI Server was estimated to be worth USD 14860 million in 2023 and is forecast to a readjusted size of USD 78810 million by 2030 with a CAGR of 16.4% during the forecast period 2024-2030.
–  The global AI Speech Recognition market was valued at USD 3856 million in 2023 and is anticipated to reach USD 17870 million by 2030, witnessing a CAGR of 24.9% during the forecast period 2024-2030.
–  The Global AI Crypto Trading Bot Market was valued at USD 21.69  Million in 2022 and is anticipated to reach USD 145.27 Million by 2029, witnessing a CAGR of 37.2% during the forecast period 2023-2029.
–  Generative AI Solution Market
–  AI Disease Detection Market
–  The AI in energy market size was valued at USD 4 billion in 2021, and is estimated to reach USD 19.8 billion by 2031, growing at a CAGR of 17.4% from 2022 to 2031.
–  The ai powered storage market size was valued at USD 15.6 billion in 2021, and is estimated to reach USD 162.5 billion by 2031, growing at a CAGR of 26.7% from 2022 to 2031.
–  The global Edge AI Software market was valued at USD 931.5 million in 2022 and is anticipated to reach USD 3519.4 million by 2029, witnessing a CAGR of 24.8% during the forecast period 2023-2029.
–  Virtual Reality 3D Scanning Market
–  The global 3D Laser Scanning Services market was valued at USD 955 million in 2023 and is anticipated to reach USD 2723.1 million by 2030, witnessing a CAGR of 16.0% during the forecast period 2024-2030.
–  Scanning Software Market
–  Profile Scanners Market
–  Transmission Scanning Imaging Systems Market
–  The global Food Scanning Technology market size is expected to reach USD 2162.6 million by 2029, growing at a CAGR of 7.3% from 2023 to 2029.
–  Document Scanning Services Market
–  The global Intraoral 3D Scanning market was valued at USD 1142 million in 2023 and is anticipated to reach USD 1878.9 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.
–  Scanning Acoustic Microscopy Equipment Market
–  Oral Scanning Devices Market
–  Sheetfed Scanner Market
–  Vulnerability Management Solution Market
–  The global Security and Vulnerability Assessment market was valued at USD 13800 million in 2023 and is anticipated to reach USD 26890 million by 2030, witnessing a CAGR of 9.5% during the forecast period 2024-2030.
–  Risk Based Vulnerability Management Tool Market
–  Vulnerability Analysis Tools Market
–  Web Application Vulnerability Scanner Market
–  Vulnerability Management Software Market
–  Hazard Vulnerability Emergency Management Market
DISCOVER OUR VISION: VISIT ABOUT US!
Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.
Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that’s why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.
To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.
YOUR FEEDBACK MATTERS: REACH OUT TO US!
Valuates [email protected] U.S. Toll-Free Call 1-(315)-215-3225WhatsApp: +91-9945648335Website: https://reports.valuates.comBlog: https://valuatestrends.blogspot.com/Pinterest: https://in.pinterest.com/valuatesreports/Twitter: https://twitter.com/valuatesreportsFacebook: https://www.facebook.com/valuatesreports/https://www.facebook.com/valuateskorean https://www.facebook.com/valuatesspanish https://www.facebook.com/valuatesjapanese https://valuatesreportspanish.blogspot.com/ https://valuateskorean.blogspot.com/ https://valuatesgerman.blogspot.com/ https://valuatesreportjapanese.blogspot.com/ 
Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/ai-vulnerability-scanning-market-size-to-grow-usd-7-574-30-million-by-2030-at-a-cagr-of-13-52–valuates-reports-302180477.html

Continue Reading

Artificial Intelligence

Timekettle Announces HybridComm 3.0 Upgrade, Marking a New Era in Near-human-level AI Translation Technology

Published

on

timekettle-announces-hybridcomm-3.0-upgrade,-marking-a-new-era-in-near-human-level-ai-translation-technology

SHENZHEN, China, June 24, 2024 /PRNewswire/ — Timekettle is excited to announce the release of its latest software upgrade, the AI Semantic Segmentation. Powered by Timekettle’s cutting-edge TurboFast Technology under HybridComm 3.0, the AI Semantic Segmentation sets a new standard in real-time language translation, solidifying Timekettle’s position as the expert in AI translator earbuds.

As the pioneer and innovator in cross-language communication solutions, Timekettle has relentlessly advanced the field through innovative products, marking a significant chapter in AI translation devices. Initially offering handheld translators for simple exchanges, Timekettle’s breakthrough came with the WT2 Plus Translator Earbuds, featuring HybridComm 1.0 for seamless, one-way translation and a speaker mode for broader communication. The subsequent launch of the WT2 Edge Real-time Translator Earbuds, with HybridComm 2.0, enabled natural, bidirectional conversations. The latest advancement, powered by HybridComm 3.0 featuring the AI Semantic Segmentation, significantly enhances translation efficiency and accuracy, marking a new era in near-human-level AI translation technology.
Leveraging the advanced TurboFast Technology, the AI Semantic Segmentation ensures a seamless and instant translation experience, helping the translated speech align perfectly with the speaker’s rhythm, and eradicating the issue of delayed translated output in crucial communication scenarios. It begins by grasping the core meaning of sentences. Once it aligns closely with the “entirely correct” benchmark, it begins translating while still processing the original voice, allowing users to hear the translated audio sooner.
Thanks to the AI Semantic Segmentation, the delay in receiving translated audio has been reduced by 200%, bringing its real-time translation capabilities on par with live interpretation. Internal test conducted recently revealed that with the AI Semantic Segmentation, a translated speech only delays a sentence lag time, while other traditional speech translation devices may experience significant delays of 30 to 40 seconds.
This significant reduction, cutting over 20 seconds of waiting time, has revolutionized continuous communication. Picture being at a conference room where attendees can instantly hear the translation of a sentence right as the speaker starts the next. Such a seamless flow of communication marks a new era of cross-language interaction, paving the way for a more connected world.
The AI Semantic Segmentation is now available on Timekettle WT2 Edge Real-time Translator Earbuds, M3 Language Translator Earbuds, and X1 AI Interpreter Hub (One-on-one mode, Listen & Play mode, and Ask & Go mode for now; Voice Call mode and more starting June 28th) and upon installing the latest software update for existing users. 
About Timekettle
Established in 2016, Timekettle is dedicated to advancing cross-language communication through innovative products and solutions. Recognized with numerous international accolades, including the CES Innovation Award, iF Design Award, and Japan Good Design Award, Timekettle’s products have proudly served the needs of cross-language communication in a variety of user scenarios, including abroad-living, traveling, multi-language meetings and classrooms, as well as in manufacturing and logistics, and beyond. Having solidified a user database of more than 400,000, Timekettle continues its journey as the Global No.1 AI Translator Device.
For further information, please visit https://www.timekettle.co/ or contact [email protected]
Photo – https://mma.prnewswire.com/media/2446107/TTS_KV_EN.jpgLogo – https://mma.prnewswire.com/media/2446212/Timekettle_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/timekettle-announces-hybridcomm-3-0-upgrade-marking-a-new-era-in-near-human-level-ai-translation-technology-302180508.html

Continue Reading

Trending